热门资讯> 正文
PetMed Express进一步推迟10-K，调查汽车运输投诉
2025-07-01 20:57
- Shares of PetMed Express (NASDAQ:PETS) are under pressure ahead of Tuesday’s open after the company disclosed that it would have to further delay Q4 and FY25 results as it continues to compile, review, and analyze the information necessary to complete its 2025 10-K.
- The company had originally filed for an extension to July 1.
- Specifically, the Board of Directors’ audit committee has received anonymous reports regarding the timing of revenue recognition of its autoship orders in Q4, some of which resulted in customer complaints.
- PetMed Express (NASDAQ:PETS) is also investigating a Q4 $50 coupon promotion and its potential impact on key performance indicators regarding new customers, as well as the company’s culture and control environment, all of which have encouraged the advice of legal counsel.
- Based on evidence gathered so far, these events are unlikely to have a material impact on preliminary Q4 results or previously filed financial results.
More on PetMed Express
- PetMed Express sees Q4 net sales between $51.1M and $53.1M
- Earnings week ahead: KR, ACN, ACB, and more
- Seeking Alpha’s Quant Rating on PetMed Express
- Historical earnings data for PetMed Express
- Financial information for PetMed Express
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
